Structures by: Quiroga J.
Total: 176
C22H25N3O2
C22H25N3O2
Organic letters (2014) 16, 16 4126-4129
a=11.1623(3)Å b=13.0760(4)Å c=27.158(1)Å
α=90° β=90° γ=90°
C29H33N3O2
C29H33N3O2
Organic letters (2014) 16, 16 4126-4129
a=25.7585(6)Å b=10.3249(2)Å c=9.5675(2)Å
α=90° β=90° γ=90°
C16H15N3
C16H15N3
Organic letters (2015) 17, 13 3374-3377
a=9.7773(2)Å b=6.90436(13)Å c=9.79548(19)Å
α=90.0° β=98.985(2)° γ=90.0°
C21H15N3
C21H15N3
Organic letters (2015) 17, 13 3374-3377
a=14.0946(2)Å b=11.4421(2)Å c=9.74761(17)Å
α=90.0° β=99.2056(17)° γ=90.0°
(3<i>RS</i>,1<i>SR</i>,2'<i>SR</i>,7a'<i>SR</i>)-2'-(4-Chlorophenyl)-1-\ benzyl-5-methyl-2''-sulfanylidene-5',6',7',7a'-tetrahydro-2'<i>H</i>-\ dispiro[indoline-3,3'-pyrrolizine-1',5''-thiazolidine]-2,4''-dione
C30H26ClN3O2S2
Acta Crystallographica Section C (2020) 76, 8
a=8.2419(2)Å b=28.0429(6)Å c=11.5843(3)Å
α=90° β=90° γ=90°
(3<i>RS</i>,1'<i>SR</i>,2'<i>SR</i>,7a'<i>SR</i>)-2'-(4-Chlorophenyl)-1-hexyl-2''-sulfanylidene-5',6',7',7a'-tetrahydro-2'<i>H</i>-dispiro[indoline-3,3'-pyrrolizine-1',5''-thiazolidine]-2,4''-dione
C28H30ClN3O2S2
Acta Crystallographica Section C (2020) 76, 8
a=14.1669(5)Å b=10.7145(3)Å c=17.1350(5)Å
α=90° β=98.6540(10)° γ=90°
6<i>H</i>-Spiro[pyrazolo[1,5-<i>c</i>]quinazoline-5,4'-thiochroman]
C18H15N3S
Acta Crystallographica Section C (2015) 71, 11
a=12.5223(8)Å b=7.6646(4)Å c=15.1729(13)Å
α=90° β=101.044(4)° γ=90°
8-methyl-7-(4-chlorophenyl)-10-phenyl-6,10-dihydro- 5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=12.1072(4)Å b=14.2672(5)Å c=12.7635(4)Å
α=90.00° β=109.953(8)° γ=90.00°
8-methyl-7-(3-pyridinyl)-10-phenyl-6,10- dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.2274(6)Å b=13.7079(8)Å c=12.6935(7)Å
α=90.00° β=95.731(3)° γ=90.00°
11-(3,4,5-trimethoxyphenyl)-10-methyl-8-phenyl-6,8- dihydro-5H-benzo[f]pyrazolo[3,4-b]quinoline
C30H27N3O3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=10.4716(9)Å b=20.0027(18)Å c=12.1529(9)Å
α=90.00° β=107.818(4)° γ=90.00°
8-methyl-7-(4-pyridinyl)-10-phenyl-10H- benzo[h]pyrazolo[3,4-b]quinoline
C26H18N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.3560(3)Å b=17.3507(5)Å c=9.7577(2)Å
α=90.00° β=97.262(2)° γ=90.00°
11-(4-methoxyphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section B (2008) 64, 1 72-83
a=18.0854(3)Å b=21.2296(5)Å c=23.8007(5)Å
α=90.00° β=108.2580(10)° γ=90.00°
11-(4-methylphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.1334(3)Å b=11.4672(2)Å c=17.6270(4)Å
α=97.858(2)° β=106.135(3)° γ=97.496(2)°
N^4^-(Cyclohexyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H18N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=11.2407(10)Å b=7.3654(5)Å c=15.8178(12)Å
α=90.00° β=106.005(7)° γ=90.00°
N^4^-Methyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H12N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=10.6661(12)Å b=7.7279(9)Å c=14.359(2)Å
α=90.00° β=100.071(7)° γ=90.00°
2-[4-(6-Amino-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]ethanol
C11H17N7O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.0297(9)Å b=13.859(3)Å c=25.766(6)Å
α=90.00° β=90.00° γ=90.00°
N^4^-(4-Methoxyphenyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
2(C13H14N6O),H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=8.9516(5)Å b=12.0627(7)Å c=12.9053(7)Å
α=91.612(4)° β=92.065(3)° γ=95.259(5)°
(4-(Pyrrolidin-1-yl)-1/H/-pyrazolo[3,4-/d/]pyrimidin-6-amine) ethanol hemisolvate hemihydrate
2(C9H12N6),C2H6O,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.9342(15)Å b=8.9219(19)Å c=16.767(3)Å
α=76.855(16)° β=83.505(14)° γ=88.003(17)°
C11H15ClN4O
C11H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=5.907(2)Å b=10.398(3)Å c=10.801(2)Å
α=110.86(3)° β=94.19(2)° γ=96.00(3)°
C9H13ClN4O
C9H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=11.328(3)Å b=8.0810(4)Å c=11.3849(12)Å
α=90.00° β=98.709(14)° γ=90.00°
C9H11ClN4O2
C9H11ClN4O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.3540(5)Å b=8.2910(13)Å c=17.276(3)Å
α=90.00° β=97.962(9)° γ=90.00°
C12H17ClN4O
C12H17ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.5722(6)Å b=8.7195(5)Å c=8.7681(7)Å
α=82.598(6)° β=82.701(5)° γ=88.645(5)°
C14H15ClN4O
C14H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.9897(5)Å b=8.0922(4)Å c=11.2786(7)Å
α=91.602(4)° β=107.220(5)° γ=91.776(5)°
C13H13ClN4O
C13H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.1811(12)Å b=8.8325(10)Å c=9.3356(6)Å
α=81.844(9)° β=82.015(10)° γ=73.041(7)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.0568(7)Å b=8.211(2)Å c=10.565(3)Å
α=84.590(16)° β=82.363(14)° γ=78.687(14)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.9938(6)Å b=7.9544(10)Å c=10.7507(14)Å
α=81.191(11)° β=82.469(12)° γ=87.333(10)°
C15H12ClN5O
C15H12ClN5O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.5716(7)Å b=16.6432(18)Å c=10.9450(7)Å
α=90.00° β=93.549(6)° γ=90.00°
C18H15ClN4O
C18H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.5520(11)Å b=11.1012(7)Å c=11.4111(4)Å
α=79.958(5)° β=84.802(9)° γ=77.009(9)°
C11H16ClN5O2
C11H16ClN5O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.2147(6)Å b=8.8563(10)Å c=10.2855(12)Å
α=84.856(10)° β=85.296(10)° γ=79.092(7)°
C10H13ClN4O
C10H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=14.4681(17)Å b=11.1378(17)Å c=7.4534(7)Å
α=90.00° β=116.535(7)° γ=90.00°
N^4^-Methyl-N^4^-(4-phenylmethyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine monohydrate
C13H14N6,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=16.5577(12)Å b=8.6833(3)Å c=18.4640(13)Å
α=90.00° β=90.00° γ=90.00°
N^4^-Ethyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
C13H14N6,0.5(H2O)
Acta Crystallographica Section B (2008) 64, 5 610-622
a=17.642(3)Å b=18.278(3)Å c=8.3034(18)Å
α=90.00° β=103.512(17)° γ=90.00°
(1<i>RS</i>,2'<i>RS</i>,3<i>SR</i>,7a'<i>SR</i>)-2'-Benzoyl-1-hexyl-2-oxo-\ 1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizine]-1'-carboxylic acid
C28H32N2O4
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1109-1115
a=19.9182(9)Å b=19.9182(9)Å c=19.9182(9)Å
α=116.980(2)° β=116.980(2)° γ=116.980(2)°
(1'<i>RS</i>,2'<i>RS</i>,3<i>SR</i>,7a'<i>SR</i>)-1',2'-Bis(4-chlorobenzoyl)-5,7-dichloro-2-oxo-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizine] dichloromethane 0.981-solvate
C28H20Cl4N2O3,0.981(CH2Cl2)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1109-1115
a=12.800(4)Å b=12.511(5)Å c=18.638(5)Å
α=90° β=99.325(12)° γ=90°
Bis-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3,4,5-trimethoxyphenylmethane
C30H32N6O3
Acta Crystallographica Section E (2004) 60, 6 o1034-o1037
a=9.7540(2)Å b=33.4646(7)Å c=8.90100(10)Å
α=90.00° β=103.6020(9)° γ=90.00°
11-(4-bromophenyl)-10-methyl-8-phenyl-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C27H20BrN3
Acta Crystallographica Section E (2005) 61, 6 o1702-o1703
a=7.0237(3)Å b=12.8964(7)Å c=13.3517(7)Å
α=106.630(3)° β=101.423(3)° γ=102.274(3)°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-di-2-thienylpentane-1,5-dione
C23H19ClN2O2S2
Acta Crystallographica Section E (2005) 61, 6 o1892-o1894
a=14.6729(5)Å b=17.8962(6)Å c=16.2619(3)Å
α=90.00° β=90.00° γ=90.00°
3,5-Dimethyl-1,7-diphenyl-4-(2-pyridinyl)-1H,7H-pyrazolo[3,4-b:4',3'-e]pyridine
C26H20N6
Acta Crystallographica Section E (2003) 59, 9 o1327-o1329
a=8.4576(2)Å b=10.6599(3)Å c=12.3642(4)Å
α=106.9170(14)° β=98.6240(16)° γ=100.803(2)°
3,5-Dimethyl-1,4,7-triphenyl-1H,7H-pyrazolo[3,4-b:4',3'-e]pyridine
C27H21N5
Acta Crystallographica Section E (2003) 59, 9 o1330-o1331
a=8.5006(2)Å b=10.5829(3)Å c=12.4093(3)Å
α=106.0775(12)° β=97.6152(15)° γ=100.6751(10)°
3,7,7-trimethyl-1-phenyl-1,6,7,8-tetrahydro-5H-pyrazolo[3,4-b]quinolin-5-one
C19H19N3O
Acta Crystallographica Section E (2003) 59, 11 o1804-o1806
a=10.6825(4)Å b=11.9254(4)Å c=13.1219(6)Å
α=111.2105(17)° β=90.5164(18)° γ=96.533(2)°
1-(p-Chlorophenyl)-3,4-dimethyl-5,6,7,8-tetrahydropyrazolo[3,4-b]quinoline
C18H18ClN3
Acta Crystallographica Section E (2003) 59, 11 o1657-o1658
a=10.2097(6)Å b=7.5773(3)Å c=20.6921(12)Å
α=90.00° β=110.203(3)° γ=90.00°
4-(4-bromophenyl)-3,7,7-trimethyl-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b] quinolin-5(6H)-one
C19H20BrN3O
Acta Crystallographica Section E (2001) 57, 2 o151-o153
a=8.6673(2)Å b=14.6092(3)Å c=14.4783(5)Å
α=90.00° β=107.2870(10)° γ=90.00°
3,7,7-Trimethyl-4-(β-naphthyl)-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]- quinolin-5(6H)-one
C23H23N3O
Acta Crystallographica Section E (2001) 57, 2 o160-o162
a=9.1222(18)Å b=15.281(3)Å c=14.346(3)Å
α=90.00° β=106.13(3)° γ=90.00°
5-(1,3-Benzothiazol-2-yliminomethyl)-2,2-dimethyl-1,3-dioxane-4,6-dione
C14H12N2O4S
Acta Crystallographica Section E (2001) 57, 2 o180-o181
a=6.3459(13)Å b=19.235(4)Å c=11.144(2)Å
α=90.00° β=103.07(3)° γ=90.00°
6-(2-Hydroxybenzoyl)-2-(4-nitrophenyl)pyrazolo[1,5-a]pyrimidine
C19H12N4O4
Acta Crystallographica Section E (2001) 57, 2 o182-o184
a=5.5421(2)Å b=11.5858(5)Å c=23.8057(13)Å
α=90.00° β=90.00° γ=90.00°
5,5-Dimethyl-3-[(5-phenyl-1H-pyrazol-3-yl)amino]cyclohex-2-en-1-one
C17H19N3O
Acta Crystallographica Section E (2001) 57, 2 o185-o186
a=19.0427(2)Å b=9.6024(4)Å c=16.6135(7)Å
α=90.00° β=90.00° γ=90.00°
6-(2-hydroxybenzoyl)-2-phenylpyrazolo[1,5-a]pyrimidine
C19H13N3O2
Acta Crystallographica Section E (2001) 57, 2 o187-o188
a=5.6606(2)Å b=11.7048(5)Å c=21.6815(10)Å
α=90.00° β=94.7970(15)° γ=90.00°
3,7,7-Trimethyl-4-(4-methoxyphenyl)-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]- quinolin-5(6H)-one (4).
C20H23N3O2
Acta Crystallographica Section E (2001) 57, 2 o154-o156
a=8.5820(3)Å b=14.7031(5)Å c=14.5369(8)Å
α=90.00° β=106.0610(15)° γ=90.00°
3,7,7-Trimethyl-4-phenyl-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]quinolin-5- (6H)-one
C19H21N3O
Acta Crystallographica Section E (2001) 57, 2 o157-o159
a=10.0870(5)Å b=14.1978(5)Å c=11.1928(8)Å
α=90.00° β=96.0340(14)° γ=90.00°
6-(1H-1,2,3-Benzotriazol-1-yl)-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline
C17H16N4
Acta Crystallographica Section E (2001) 57, 2 o178-o179
a=10.7112(3)Å b=10.8297(3)Å c=23.6321(5)Å
α=90.00° β=90.00° γ=90.00°
5-[(6-Chloro-[1,3]benzothiazol-2-ylamino)-methylene]-2,2-dimethyl- [1,3]dioxane-4,6-dione
C14H11ClN2O4S
Acta Crystallographica Section E (2002) 58, 1 o57-o58
a=5.3389(4)Å b=28.583(2)Å c=9.8618(8)Å
α=90.00° β=109.178(4)° γ=90.00°
(E)-3-(4-Chlorophenyl)-2-(2-thienyl)acrylonitrile
C13H8ClNS
Acta Crystallographica Section E (2005) 61, 11 o3639-o3641
a=3.8142(2)Å b=23.6852(8)Å c=12.5319(5)Å
α=90.00° β=97.2160(16)° γ=90.00°
11-Chloro-5H-6,7-dihydrobenzothiazolo[2,3-b]benzo[h]quinazoline
C18H13Cl1N2S1
Acta Crystallographica Section E (2001) 57, 10 o937-o938
a=7.2637(3)Å b=14.4294(5)Å c=15.1081(5)Å
α=70.368(3)° β=78.550(2)° γ=89.0800(14)°
3-tert-Butyl-1-(4-chlorophenyl)-7,7-dimethyl-5,6,7,8- tetrahydroimidazo[3,4-b]quinolin-5-one
C22H24ClN3O
Acta Crystallographica Section E (2005) 61, 1 o49-o51
a=8.6851(11)Å b=10.6167(9)Å c=12.4330(12)Å
α=106.724(8)° β=101.049(10)° γ=107.406(8)°
11-(4-chlorophenyl)-10-methyl-8-phenyl-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section E (2005) 61, 4 o1058-o1060
a=7.12700(10)Å b=12.6300(4)Å c=13.2847(4)Å
α=107.3380(13)° β=103.6230(17)° γ=101.4230(18)°
5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde
C11H9ClN2O
Acta Crystallographica Section E (2005) 61, 4 o1055-o1057
a=6.5683(2)Å b=6.7921(2)Å c=22.4418(6)Å
α=90.00° β=94.206(2)° γ=90.00°
5-[(Dimethylamino)methyleneamino]-3-methyl-1-phenylpyrazole
C13H16N4
Acta Crystallographica Section C (1999) 55, 12 2096-2098
a=9.1149(6)Å b=7.5153(4)Å c=18.1463(8)Å
α=90.00° β=92.030(10)° γ=90.00°
5-Cyano-4-(4-methoxyphenyl)-3,6-diphenyl-4,7-dihydro-2H-pyrazolo- [3,4-b]pyridine
C26H20N4O
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=15.6264(3)Å b=12.4397(2)Å c=21.1296(4)Å
α=90.00° β=91.4371(9)° γ=90.00°
3,4-Bis(4-chlorophenyl)-5-cyano-6-phenyl-1H-pyrazolo-[3,4-b]pyridine
C25H14Cl2N4
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=6.6222(5)Å b=11.0791(10)Å c=28.264(2)Å
α=90.00° β=96.248(5)° γ=90.00°
4-(4-chlorophenyl)-5-cyano-3-(4-methylphenyl)-6-diphenyl-4,7-dihydro-2H-pyrazolo [3,4-b]pyridine:dimethylformamide (2/1)
2C26H19ClN4,C3H7NO
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=12.4124(5)Å b=13.8275(4)Å c=14.3744(6)Å
α=91.747(2)° β=106.6376(17)° γ=99.610(2)°
8-tert-Butyl-7,10-diphenyl-6,10-dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C30H27N3
Acta Crystallographica Section E (2007) 63, 5 o2690-o2691
a=9.516(2)Å b=10.406(3)Å c=11.868(5)Å
α=99.52(4)° β=100.42(2)° γ=91.55(4)°
N,N'-Bis(isonicotinoyl)hydrazine dihydrate
C12H10N4O2,2H2O
Acta Crystallographica Section E (2007) 63, 4 o1687-o1690
a=28.1492(15)Å b=24.1628(13)Å c=3.7181(5)Å
α=90.00° β=90.00° γ=90.00°
4-(4-fluorophenyl)-3-methyl-1- phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-one
C26H16FN3O
Acta Crystallographica Section E (2006) 62, 11 o5176-o5178
a=8.7566(3)Å b=9.9924(2)Å c=11.9100(4)Å
α=73.359(2)° β=78.009(2)° γ=81.238(2)°
5-Amino-3-tert-butyl-1-(4-nitrophenyl)-1H-pyrazole
C13H16N4O2
Acta Crystallographica Section C (2004) 60, 3 o194-o195
a=5.9581(2)Å b=18.3064(11)Å c=12.0776(7)Å
α=90.00° β=93.4150(12)° γ=90.00°
4-Amino-1-methyl-5-(2-hydroxy-4,4-dimethyl-2-oxocyclohexenylmethyl)- 2-(methylsulfanyl)pyrimidin-6(1H)-one
C15H21N3O3S
Acta Crystallographica Section C (2004) 60, 3 o191-o193
a=7.5524(2)Å b=7.1370(3)Å c=28.6208(11)Å
α=90.00° β=93.128(2)° γ=90.00°
5-(4-Chlorophenyl)-2-methoxyindeno[1',2':2,3]pyrido[5,6-d]pyrimidine- 4,6(3H,5H)-dione--dimethylformamide (1/1)
C21H14ClN3O3,C3H7NO
Acta Crystallographica Section C (2004) 60, 3 o186-o190
a=10.6850(6)Å b=17.6182(12)Å c=12.3774(8)Å
α=90.00° β=108.523(4)° γ=90.00°
(5RS,5aSR,10bSR)-10b-hydroxy-2-methoxy-5-(4-methoxyphenyl)-5a-10b- dihydroindeno[1',2':2,3]pyrido[5,6-d]pyrimidine-4,6(3H,5H)-dione-- dimethylformamide (1/1)
C22H19N3O5,C3H7NO
Acta Crystallographica Section C (2004) 60, 3 o186-o190
a=10.4172(2)Å b=10.8540(3)Å c=11.6112(3)Å
α=94.2692(12)° β=116.0676(12)° γ=94.4530(13)°
3-tert-Butyl-7,7-dimethyl-1-phenyl-5,6,7,8- tetrahydroimidazo[3,4-b]quinolin-5-one
C22H25N3O
Acta Crystallographica Section C (2004) 60, 7 o479-o482
a=6.1514(2)Å b=10.3171(5)Å c=15.7351(8)Å
α=71.722(2)° β=85.780(3)° γ=85.306(3)°
2,8,8-Trimethyl-5-phenyl-6,7,8,9-tetrahydroimidazo[2,3-a]quinolin-6-one
C19H19N3O
Acta Crystallographica Section C (2004) 60, 7 o479-o482
a=7.7988(3)Å b=17.0950(6)Å c=12.0231(3)Å
α=90° β=108.8000(18)° γ=90°
(<i>E</i>)-3-(4-Methylphenyl)-2-(2-thienyl)acrylonitrile
C14H11N1S1
Acta Crystallographica Section C (2009) 65, 9 o444-o446
a=21.4869(7)Å b=7.0302(3)Å c=14.1810(5)Å
α=90.00° β=126.173(2)° γ=90.00°
2,8,8-Trimethyl-6,7,8,9-tetrahydropyrazolo[2,3-a]quinazolin-6-one
C13H15N3O
Acta Crystallographica Section C (2004) 60, 4 o265-o269
a=5.9856(3)Å b=18.1464(9)Å c=10.7139(4)Å
α=90.00° β=98.457(3)° γ=90.00°
3-tert-Butyl-4',4'-dimethyl-1-phenyl-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-b]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C23H29N3O2
Acta Crystallographica Section C (2004) 60, 4 o265-o269
a=10.0469(2)Å b=16.4547(4)Å c=12.7983(2)Å
α=90.00° β=108.4950(12)° γ=90.00°
4',4'-Dimethyl-2-methylsulfanyl-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidine- 6-spiro-1'-cyclohexane-2',4,6'-trione
C15H19N3O3S
Acta Crystallographica Section C (2004) 60, 6 o438-o443
a=7.8990(3)Å b=10.0386(3)Å c=10.0500(3)Å
α=74.938(2)° β=84.271(2)° γ=81.842(2)°
8-Ethoxymethyl-4',4'-dimethyl-2-methoxy-3,4,5,6,7,8- hexahydropyrido[2,3-d]pyrimidine-6-spiro-1'-cyclohexane-2',4,6'-trione
C18H25N3O5
Acta Crystallographica Section C (2004) 60, 6 o438-o443
a=8.9219(5)Å b=9.9806(5)Å c=11.3542(7)Å
α=75.662(3)° β=85.580(3)° γ=66.526(3)°
8-Hydroxymethyl-4',4'-dimethyl-2-methylsulfanyl-3,4,5,6,7,8- hexahydropyrido[2,3-d]pyrimidine-6-spiro-1'-cyclohexane-2',4,6'-trione
C16H21N3O4S
Acta Crystallographica Section C (2004) 60, 6 o438-o443
a=6.6682(2)Å b=11.0319(3)Å c=12.3449(4)Å
α=109.2678(18)° β=99.8329(18)° γ=101.227(2)°
5-methyl-2-(4-methylphenyl)-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C17H17N3
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.2882(7)Å b=6.8383(4)Å c=15.1947(8)Å
α=90.00° β=104.018(3)° γ=90.00°
3,7,7-Trimethyl-1-phenyl-5,6,7,8-tetrahydropyrazolo[3,4-b]quinolin-5-one
C19H19N3O
Acta Crystallographica Section C (2005) 61, 7 o442-o444
a=11.1485(12)Å b=12.3739(15)Å c=11.7412(12)Å
α=90.00° β=108.894(6)° γ=90.00°
2-(4-chlorophenyl)-5-methyl-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C16H14ClN3
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.6800(11)Å b=6.6669(6)Å c=15.2010(16)Å
α=90.00° β=106.980(6)° γ=90.00°
(4-methoxyphenyl)-5-methyl- 7,8-dihydro-6H-cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C17H17N3O
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=9.4691(3)Å b=8.1711(2)Å c=18.0278(6)Å
α=90.00° β=95.3430(14)° γ=90.00°
8-methyl-10-phenyl-6,10-dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=7.0870(2)Å b=10.1321(4)Å c=11.7977(5)Å
α=87.501(2)° β=73.171(3)° γ=74.828(2)°
8-methyl-7,10-diphenyl-6,10-dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H21N3
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=11.5561(4)Å b=17.6751(7)Å c=9.8469(3)Å
α=90.00° β=98.599(2)° γ=90.00°
8-methyl-7-(4-methylphenyl)-10-phenyl-6,10-dihydro-5H- benzo[h]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=12.0313(3)Å b=14.3347(4)Å c=12.7956(3)Å
α=90.00° β=109.3092(14)° γ=90.00°
7-(4-methoxyphenyl)-8-methyl-10-phenyl-6,10-dihydro-5H- benzo[h]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=12.9148(3)Å b=17.5938(5)Å c=9.8192(2)Å
α=90.00° β=104.3370(17)° γ=90.00°
(Z)-5-benzylidenene-2-thioxothiazolidin-4-one
C10H7NOS2
Acta Crystallographica Section C (2005) 61, 8 o477-o482
a=11.7286(3)Å b=7.0215(2)Å c=23.7552(6)Å
α=90.00° β=100.2630(12)° γ=90.00°
(Z)-5-(4-methylbenzylidenene)-2-thioxothiazolidin-4-one
C11H9NOS2
Acta Crystallographica Section C (2005) 61, 8 o477-o482
a=4.94280(10)Å b=20.0473(8)Å c=10.7834(4)Å
α=90.00° β=90.753(2)° γ=90.00°
(Z)-2-thioxo-5-(4-trifluoromethylbenzylidenene)thiazolidin-4-one
C11H6F3NOS2
Acta Crystallographica Section C (2005) 61, 8 o477-o482
a=5.2859(2)Å b=6.2263(3)Å c=17.1885(8)Å
α=91.753(2)° β=95.326(3)° γ=90.129(3)°
2-(4-bromophenyl)-5-methyl-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C16H14BrN3
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.5387(6)Å b=6.8551(2)Å c=15.2767(7)Å
α=90.00° β=105.708(2)° γ=90.00°
2-(4-Chlorophenyl)-5-(4-nitrophenyl)-4,7- dihydropyrazolo[1,5-<i>a</i>]pyrimidine-3,6-dicarbaldehyde
C20H13ClN4O4
Acta Crystallographica Section C (2008) 64, 6 o341-o343
a=23.943(5)Å b=13.445(2)Å c=12.336(5)Å
α=90.00° β=118.594(10)° γ=90.00°
(<i>E</i>)-3-Dimethylamino-2-(1<i>H</i>-indol-3-ylcarbonyl)acrylonitrile
C14H13N3O
Acta Crystallographica Section C (2008) 64, 7 o385-o387
a=11.5945(5)Å b=8.6412(6)Å c=23.1522(18)Å
α=90.00° β=92.325(7)° γ=90.00°
10-Ethyl-4-oxo-2,3,4,10-tetrahydropyrimido[4,5-b]quinolin-2-iminium 4-toluenesulfonate
C13H13N4O,C7H7O3S
Acta Crystallographica Section C (2008) 64, 7 o382-o384
a=9.0213(7)Å b=20.2880(18)Å c=10.3932(6)Å
α=90.00° β=90.245(5)° γ=90.00°
<i>N</i>^4^-Methyl-<i>N</i>^4^-(2-methylphenyl)-1<i>H</i>-pyrazolo[3,4- <i>d</i>]pyrimidine-4,6-diamine--ethanol--hydrazine (1/0.865/0.135)
C13H14N6,0.865(C2H6O1),0.135(N2H4)
Acta Crystallographica Section C (2009) 65, 6 o293-o295
a=16.349(3)Å b=14.051(2)Å c=13.625(3)Å
α=90.00° β=99.308(18)° γ=90.00°
3-Methyl-7-(2-thienyl)pyrido[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)- dione
C12H9N3O2S
Acta Crystallographica Section C (2009) 65, 6 o284-o286
a=12.1969(15)Å b=13.4010(13)Å c=6.6071(8)Å
α=90.00° β=92.134(11)° γ=90.00°
(3<i>Z</i>)-3-{1-[(5-phenyl-1<i>H</i>-pyrazol-3-yl)amino]ethylidene}-4,5- dihydrofuran-2(3<i>H</i>)-one
C15H15N3O2
Acta Crystallographica Section C (2010) 66, 1 o25-o28
a=10.4969(17)Å b=9.8550(9)Å c=12.6739(16)Å
α=90.00° β=99.883(9)° γ=90.00°
(3<i>Z</i>)-3-{1-[(5-methyl-1<i>H</i>-pyrazol-3-yl)amino]ethylidene}-4,5- dihydrofuran-2(3<i>H</i>)-one--6-(2-hydroxyethyl)-2,5- dimethylpyrazolo[1,5-<i>a</i>]pyrimidin-7(4<i>H</i>)-one (1/1)
C10H13N3O2,C10H13N3O2
Acta Crystallographica Section C (2010) 66, 1 o25-o28
a=8.0402(11)Å b=8.2025(17)Å c=15.348(3)Å
α=91.999(14)° β=99.785(12)° γ=99.172(15)°
2-cyano-<i>N</i>-(2,6-dimethoxypyrimidin-4-yl)-3-[4- (dimethylamino)phenyl]acrylamide
C18H19N5O3
Acta Crystallographica Section C (2010) 66, 1 o39-o43
a=7.9772(2)Å b=10.0023(4)Å c=10.8409(5)Å
α=93.693(2)° β=93.562(3)° γ=99.196(2)°
Dimethylammonium 6-cyano-1,3-dimethyl-2,4,5-trioxo-1,2,3,4,5,8- hexahydropyrido[2,3-<i>d</i>]pyrimidin-8-ide
C2H8N,C10H7N4O3
Acta Crystallographica Section C (2010) 66, 1 o39-o43
a=8.1520(5)Å b=9.2984(8)Å c=9.7299(8)Å
α=69.609(3)° β=70.741(4)° γ=79.447(5)°
5-Amino-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde hemihydrate
C11H11N3O1,0.5H2O
Acta Crystallographica Section C (2010) 66, 1 o47-o49
a=10.8346(14)Å b=7.4952(9)Å c=24.621(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl (3a<i>RS</i>,3c<i>RS</i>,6c<i>SR</i>,7<i>RS</i>,8<i>RS</i>,8a<i>SR</i>)- 2,5-bis(4-chlorophenyl)-7,9-bis(1,3-diphenyl-1<i>H</i>-pyrazol-4-yl)-1,3,4,6- tetraoxododecahydro-1<i>H</i>-dipyrrolo[3,4-<i>a</i>:3',4'- <i>f</i>]pyrrolizine-3b-carboxylate dimethylformamide disolvate
C55H39Cl2N7O6,2(C3H7NO)
Acta Crystallographica Section C (2012) 68, 11 o439-o442
a=13.948(3)Å b=14.279(3)Å c=16.3474(16)Å
α=70.147(12)° β=86.297(13)° γ=62.265(16)°
2-Amino-4-(4-chlorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro- 4H-chromene-3-carbonitrile
C18H17ClN2O2
Acta Crystallographica Section C (2003) 59, 1 o38-o39
a=9.3867(3)Å b=16.5328(5)Å c=11.3189(3)Å
α=90° β=118.118(2)° γ=90°
6-Amino-2-(3,4-dimethoxybenzylamino)-3-methyl-5-nitroso-pyrimidin-4(3H)-one
C14H17N5O4
Acta Crystallographica Section C (2003) 59, 5 o237-o239
a=12.8488(10)Å b=7.4416(10)Å c=16.962(2)Å
α=90.00° β=113.728(8)° γ=90.00°